Zobrazeno 1 - 10 of 948 pro vyhledávání: '"ipragliflozin"'
1
Akademický článek
Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes: the SUCRE study.
Autor: Nagao, Mototsugu1 (AUTHOR), Sasaki, Jun2 (AUTHOR), Tanimura-Inagaki, Kyoko1 (AUTHOR), Sakuma, Ichiro3 (AUTHOR), Sugihara, Hitoshi1 (AUTHOR), Oikawa, Shinichi1,4 (AUTHOR) shinichi@nms.ac.jp
Publikováno v: Cardiovascular Diabetology. 2/8/2024, Vol. 23 Issue 1, p1-12. 12p.
Zobrazit plný text záznamu
2
Akademický článek
Long-term observation of estimated fluid volume reduction after the initiation of ipragliflozin in patients with type 2 diabetes mellitus: a sub-analysis from a randomized controlled trial (PROTECT).
Autor: Tanaka, Atsushi1 (AUTHOR) tanakaa2@cc.saga-u.ac.jp, Imai, Takumi2 (AUTHOR), Toyoda, Shigeru3 (AUTHOR), Sugimoto, Kazuhiro4 (AUTHOR), Yoshida, Ruka5 (AUTHOR), Furuta, Machi6 (AUTHOR), Node, Koichi1 (AUTHOR) node@cc.saga-u.ac.jp
Publikováno v: Diabetology & Metabolic Syndrome. 7/7/2023, Vol. 15 Issue 1, p1-11. 11p.
Zobrazit plný text záznamu
3
Akademický článek
Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study.
Autor: Kishimoto, Shinji1 (AUTHOR), Higashi, Yukihito1,2 (AUTHOR) yhigashi@hiroshima-u.ac.jp, Imai, Takumi3 (AUTHOR), Eguchi, Kazuo4 (AUTHOR), Fukumoto, Kazuo5 (AUTHOR), Tomiyama, Hirofumi6 (AUTHOR), Maemura, Koji7 (AUTHOR), Tanaka, Atsushi8 (AUTHOR), Node, Koichi8 (AUTHOR), Murohara, Toyoaki (AUTHOR), Kitakaze, Masafumi (AUTHOR), Nishio, Yoshihiko (AUTHOR), Inoue, Teruo (AUTHOR), Ohishi, Mitsuru (AUTHOR), Kario, Kazuomi (AUTHOR), Sata, Masataka (AUTHOR), Shimabukuro, Michio (AUTHOR), Shimizu, Wataru (AUTHOR), Jinnouchi, Hideaki (AUTHOR), Taguchi, Isao (AUTHOR)
Publikováno v: Cardiovascular Diabetology. 5/20/2023, Vol. 22 Issue 1, p1-9. 9p.
Zobrazit plný text záznamu
6
Akademický článek
Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.
Autor: Parveen, Rizwana, Hussain, Shadan, Saini, Sparsh, Khan, Parvej, Saha, Nilanjan, Nidhi
Publikováno v: Expert Opinion on Pharmacotherapy; May2024, Vol. 25 Issue 7, p925-935, 11p
Zobrazit plný text záznamu
8
Akademický článek
Long-term observation of estimated fluid volume reduction after the initiation of ipragliflozin in patients with type 2 diabetes mellitus: a sub-analysis from a randomized controlled trial (PROTECT)
Autor: Atsushi Tanaka, Takumi Imai, Shigeru Toyoda, Kazuhiro Sugimoto, Ruka Yoshida, Machi Furuta, Koichi Node, the PROTECT Investigators
Publikováno v: Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-11 (2023)
Abstract Backgrounds/Aim Recent studies have shown that the addition of sodium-glucose co-transporter 2 (SGLT2) inhibitors gradually reduces the estimated fluid volume parameters in a broad range of patient populations, suggesting that this mediates
Externí odkaz: https://doaj.org/article/d847f9b4700d47ea961043b8d4623dc0
Zobrazit plný text záznamu
9
Akademický článek
C-Aryl Glycosylation via Interrupted Pummerer Rearrangement.
Autor: Jiagen Li, Xuefeng Jiang
Publikováno v: Chinese Journal of Chemistry; Nov2023, Vol. 41 Issue 21, p2843-2847, 5p
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje